Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

NK cell recruitment limits tissue damage during an enteric helminth infection.

Gentile ME, Li Y, Robertson A, Shah K, Fontes G, Kaufmann E, Polese B, Khan N, Parisien M, Munter HM, Mandl JN, Diatchenko L, Divangahi M, King IL.

Mucosal Immunol. 2019 Nov 27. doi: 10.1038/s41385-019-0231-8. [Epub ahead of print]

PMID:
31776431
2.

Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1.

Layoun A, Goldberg AA, Baig A, Eng M, Attias O, Nelson K, Carella A, Amberber N, Fielhaber JA, Joung KB, Martin Schmeing T, Han Y, Downey J, Divangahi M, Roux PP, Kristof AS.

Sci Rep. 2019 Nov 26;9(1):17620. doi: 10.1038/s41598-019-53909-5.

3.

[Loss of human ICOSLG results in combined immunodeficiency].

Roussel L, Landekic M, Golizeh M, Gavino C, Zhong MC, Chen J, Faubert D, Blanchet-Cohen A, Dansereau L, Parent MA, Marin S, Luo J, Le C, Ford BR, Langelier M, King IL, Divangahi M, Foulkes WD, Veillette A, Vinh DC.

Med Sci (Paris). 2019 Aug-Sep;35(8-9):625-628. doi: 10.1051/medsci/2019126. Epub 2019 Sep 18. French. No abstract available.

PMID:
31532372
4.

Targeting innate immunity for tuberculosis vaccination.

Khader SA, Divangahi M, Hanekom W, Hill PC, Maeurer M, Makar KW, Mayer-Barber KD, Mhlanga MM, Nemes E, Schlesinger LS, van Crevel R, Vankalayapati R, Xavier RJ, Netea MG; Bill and Melinda Gates Foundation Collaboration for TB Vaccine Discovery Innate Immunity Working Group18.

J Clin Invest. 2019 Sep 3;129(9):3482-3491. doi: 10.1172/JCI128877. Review.

5.

Tolerogenic signaling of alveolar macrophages induces lung adaptation to oxidative injury.

Allard B, Panariti A, Pernet E, Downey J, Ano S, Dembele M, Nakada E, Fujii U, McGovern TK, Powell WS, Divangahi M, Martin JG.

J Allergy Clin Immunol. 2019 Oct;144(4):945-961.e9. doi: 10.1016/j.jaci.2019.07.015. Epub 2019 Jul 26.

PMID:
31356919
6.

The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signaling.

Abdel-Nour M, Carneiro LAM, Downey J, Tsalikis J, Outlioua A, Prescott D, Da Costa LS, Hovingh ES, Farahvash A, Gaudet RG, Molinaro R, van Dalen R, Lau CCY, Azimi FC, Escalante NK, Trotman-Grant A, Lee JE, Gray-Owen SD, Divangahi M, Chen JJ, Philpott DJ, Arnoult D, Girardin SE.

Science. 2019 Jul 5;365(6448). pii: eaaw4144. doi: 10.1126/science.aaw4144.

PMID:
31273097
7.

Necroptotic cell binding of β2 -glycoprotein I provides a potential autoantigenic stimulus in systemic lupus erythematosus.

Salem D, Subang R, Pernet E, Divangahi M, Pineau C, Cayrol R, Levine JS, Rauch J.

Immunol Cell Biol. 2019 Oct;97(9):799-814. doi: 10.1111/imcb.12279. Epub 2019 Jun 12.

PMID:
31187539
8.

Leukotriene B4-type I interferon axis regulates macrophage-mediated disease tolerance to influenza infection.

Pernet E, Downey J, Vinh DC, Powell WS, Divangahi M.

Nat Microbiol. 2019 Aug;4(8):1389-1400. doi: 10.1038/s41564-019-0444-3. Epub 2019 May 20.

PMID:
31110361
9.

Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis.

Khan N, Mendonca L, Dhariwal A, Fontes G, Menzies D, Xia J, Divangahi M, King IL.

Mucosal Immunol. 2019 May;12(3):772-783. doi: 10.1038/s41385-019-0147-3. Epub 2019 Feb 19.

PMID:
30783183
10.

Beyond Killing Mycobacterium tuberculosis: Disease Tolerance.

Divangahi M, Khan N, Kaufmann E.

Front Immunol. 2018 Dec 19;9:2976. doi: 10.3389/fimmu.2018.02976. eCollection 2018. Review.

11.

Loss of human ICOSL results in combined immunodeficiency.

Roussel L, Landekic M, Golizeh M, Gavino C, Zhong MC, Chen J, Faubert D, Blanchet-Cohen A, Dansereau L, Parent MA, Marin S, Luo J, Le C, Ford BR, Langelier M, King IL, Divangahi M, Foulkes WD, Veillette A, Vinh DC.

J Exp Med. 2018 Dec 3;215(12):3151-3164. doi: 10.1084/jem.20180668.

12.

Are tolerance and training required to end TB?

Divangahi M.

Nat Rev Immunol. 2018 Nov;18(11):661-663. doi: 10.1038/s41577-018-0070-y. No abstract available.

PMID:
30267017
13.

Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles.

Chennakrishnaiah S, Meehan B, D'Asti E, Montermini L, Lee TH, Karatzas N, Buchanan M, Tawil N, Choi D, Divangahi M, Basik M, Rak J.

J Thromb Haemost. 2018 Sep;16(9):1800-1813. doi: 10.1111/jth.14222. Epub 2018 Aug 16.

PMID:
29971917
14.

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Tzelepis F, Blagih J, Khan N, Gillard J, Mendonca L, Roy DG, Ma EH, Joubert P, Jones RG, Divangahi M.

Sci Immunol. 2018 May 11;3(23). pii: eaar4135. doi: 10.1126/sciimmunol.aar4135.

PMID:
29752301
15.

Dissecting host cell death programs in the pathogenesis of influenza.

Downey J, Pernet E, Coulombe F, Divangahi M.

Microbes Infect. 2018 Oct - Nov;20(9-10):560-569. doi: 10.1016/j.micinf.2018.03.005. Epub 2018 Apr 18. Review.

PMID:
29679740
16.

Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.

Khan N, Divangahi M.

J Infect Dis. 2018 May 25;217(12):1851-1853. doi: 10.1093/infdis/jix626. No abstract available.

PMID:
29432590
17.

Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation by B cells.

Kim JH, Podstawka J, Lou Y, Li L, Lee EKS, Divangahi M, Petri B, Jirik FR, Kelly MM, Yipp BG.

Nat Immunol. 2018 Feb;19(2):192-201. doi: 10.1038/s41590-017-0030-x. Epub 2018 Jan 15.

PMID:
29335647
18.

BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis.

Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonça LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, Mailhot-Léonard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M.

Cell. 2018 Jan 11;172(1-2):176-190.e19. doi: 10.1016/j.cell.2017.12.031.

19.

Cracking the Vaccine Code in Tuberculosis.

Divangahi M, Behr MA.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):427-432. doi: 10.1164/rccm.201707-1489PP. Review. No abstract available.

PMID:
29045159
20.

RIPK3 interacts with MAVS to regulate type I IFN-mediated immunity to Influenza A virus infection.

Downey J, Pernet E, Coulombe F, Allard B, Meunier I, Jaworska J, Qureshi S, Vinh DC, Martin JG, Joubert P, Divangahi M.

PLoS Pathog. 2017 Apr 14;13(4):e1006326. doi: 10.1371/journal.ppat.1006326. eCollection 2017 Apr.

21.

Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages.

Zhao X, Khan N, Gan H, Tzelepis F, Nishimura T, Park SY, Divangahi M, Remold HG.

Mucosal Immunol. 2017 Nov;10(6):1553-1568. doi: 10.1038/mi.2017.12. Epub 2017 Apr 12.

22.

Unravelling the networks dictating host resistance versus tolerance during pulmonary infections.

Meunier I, Kaufmann E, Downey J, Divangahi M.

Cell Tissue Res. 2017 Mar;367(3):525-536. doi: 10.1007/s00441-017-2572-5. Epub 2017 Feb 6. Review.

PMID:
28168323
23.

Intestinal helminth infection impacts the systemic distribution and function of the naive lymphocyte pool.

King IL, Mohrs K, Meli AP, Downey J, Lanthier P, Tzelepis F, Fritz JH, Tumanov AV, Divangahi M, Leadbetter EA, Mohrs M.

Mucosal Immunol. 2017 Sep;10(5):1160-1168. doi: 10.1038/mi.2016.127. Epub 2017 Jan 25.

24.

Semaphorin 4C Protects against Allergic Inflammation: Requirement of Regulatory CD138+ Plasma Cells.

Xue D, Kaufman GN, Dembele M, Beland M, Massoud AH, Mindt BC, Fiter R, Fixman ED, Martin JG, Friedel RH, Divangahi M, Fritz JH, Mazer BD.

J Immunol. 2017 Jan 1;198(1):71-81. Epub 2016 Nov 23.

25.

Tuberculosis.

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, Ginsberg A, Swaminathan S, Spigelman M, Getahun H, Menzies D, Raviglione M.

Nat Rev Dis Primers. 2016 Oct 27;2:16076. doi: 10.1038/nrdp.2016.76. Review.

PMID:
27784885
26.

Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.

Mojumdar K, Giordano C, Lemaire C, Liang F, Divangahi M, Qureshi ST, Petrof BJ.

J Pathol. 2016 May;239(1):10-22. doi: 10.1002/path.4689. Epub 2016 Mar 16.

PMID:
26800321
27.

Efferocytosis: Burying cell corpses to regulate tolerance and immunity.

Divangahi M.

Oncotarget. 2015 Jun 20;6(17):14721-2. No abstract available.

28.

Evolution of the Immune Response to Chronic Airway Colonization with Aspergillus fumigatus Hyphae.

Urb M, Snarr BD, Wojewodka G, Lehoux M, Lee MJ, Ralph B, Divangahi M, King IL, McGovern TK, Martin JG, Fraser R, Radzioch D, Sheppard DC.

Infect Immun. 2015 Sep;83(9):3590-600. doi: 10.1128/IAI.00359-15. Epub 2015 Jun 29.

29.

Alveolar macrophages and type I IFN in airway homeostasis and immunity.

Divangahi M, King IL, Pernet E.

Trends Immunol. 2015 May;36(5):307-14. doi: 10.1016/j.it.2015.03.005. Epub 2015 Apr 3. Review.

PMID:
25843635
30.

The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.

Blagih J, Coulombe F, Vincent EE, Dupuy F, Galicia-Vázquez G, Yurchenko E, Raissi TC, van der Windt GJ, Viollet B, Pearce EL, Pelletier J, Piccirillo CA, Krawczyk CM, Divangahi M, Jones RG.

Immunity. 2015 Jan 20;42(1):41-54. doi: 10.1016/j.immuni.2014.12.030. Epub 2015 Jan 2.

31.

Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.

Tzelepis F, Verway M, Daoud J, Gillard J, Hassani-Ardakani K, Dunn J, Downey J, Gentile ME, Jaworska J, Sanchez AM, Nédélec Y, Vali H, Tabrizian M, Kristof AS, King IL, Barreiro LB, Divangahi M.

J Clin Invest. 2015 Feb;125(2):752-68. doi: 10.1172/JCI77014. Epub 2014 Dec 22.

32.

Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy.

Giordano C, Mojumdar K, Liang F, Lemaire C, Li T, Richardson J, Divangahi M, Qureshi S, Petrof BJ.

Hum Mol Genet. 2015 Apr 15;24(8):2147-62. doi: 10.1093/hmg/ddu735. Epub 2014 Dec 30.

33.

Freund's adjuvant, NOD2 and mycobacteria.

Behr MA, Divangahi M.

Curr Opin Microbiol. 2015 Feb;23:126-32. doi: 10.1016/j.mib.2014.11.015. Epub 2014 Dec 5. Review.

PMID:
25483349
34.

Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2.

Mojumdar K, Liang F, Giordano C, Lemaire C, Danialou G, Okazaki T, Bourdon J, Rafei M, Galipeau J, Divangahi M, Petrof BJ.

EMBO Mol Med. 2014 Nov;6(11):1476-92. doi: 10.15252/emmm.201403967.

35.

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

Coulombe F, Divangahi M.

Expert Rev Anti Infect Ther. 2014 Nov;12(11):1337-43. doi: 10.1586/14787210.2014.966082. Epub 2014 Sep 30. Review.

PMID:
25269880
36.

NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.

Jaworska J, Coulombe F, Downey J, Tzelepis F, Shalaby K, Tattoli I, Berube J, Rousseau S, Martin JG, Girardin SE, McCullers JA, Divangahi M.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):E2110-9. doi: 10.1073/pnas.1322118111. Epub 2014 May 5.

37.

Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.

Coulombe F, Jaworska J, Verway M, Tzelepis F, Massoud A, Gillard J, Wong G, Kobinger G, Xing Z, Couture C, Joubert P, Fritz JH, Powell WS, Divangahi M.

Immunity. 2014 Apr 17;40(4):554-68. doi: 10.1016/j.immuni.2014.02.013. Epub 2014 Apr 10.

38.

N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis.

Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MV, Schlesinger LS, Divangahi M, Reed MB, Behr MA.

J Infect Dis. 2014 Apr 1;209(7):1045-54. doi: 10.1093/infdis/jit622. Epub 2013 Nov 21.

PMID:
24265438
39.

Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection.

Verway M, Bouttier M, Wang TT, Carrier M, Calderon M, An BS, Devemy E, McIntosh F, Divangahi M, Behr MA, White JH.

PLoS Pathog. 2013;9(6):e1003407. doi: 10.1371/journal.ppat.1003407. Epub 2013 Jun 6.

40.

Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis.

Divangahi M, Behar SM, Remold H.

Adv Exp Med Biol. 2013;783:103-20. doi: 10.1007/978-1-4614-6111-1_6. Review.

41.

Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, Brown EG, Hogaboam CM, Gauldie J, Xing Z.

Am J Pathol. 2011 Dec;179(6):2963-76. doi: 10.1016/j.ajpath.2011.09.003. Epub 2011 Oct 14.

42.

Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis.

Behar SM, Martin CJ, Nunes-Alves C, Divangahi M, Remold HG.

Microbes Infect. 2011 Aug;13(8-9):749-56. doi: 10.1016/j.micinf.2011.03.002. Epub 2011 Mar 31. Review.

43.

Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis.

Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, Gan HX, Divangahi M, Remold HG.

Mucosal Immunol. 2011 May;4(3):279-87. doi: 10.1038/mi.2011.3. Epub 2011 Feb 9. Review.

44.

CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.

Bassett JD, Yang TC, Bernard D, Millar JB, Swift SL, McGray AJ, VanSeggelen H, Boudreau JE, Finn JD, Parsons R, Evelegh C, Damjanovic D, Grinshtein N, Divangahi M, Zhang L, Xing Z, Wan Y, Bramson JL.

Blood. 2011 Jan 27;117(4):1146-55. doi: 10.1182/blood-2010-03-272336. Epub 2010 Nov 18.

PMID:
21088134
45.

Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.

Labbe K, Danialou G, Gvozdic D, Demoule A, Divangahi M, Boyd JH, Petrof BJ.

Crit Care. 2010;14(5):R187. doi: 10.1186/cc9295. Epub 2010 Oct 7.

46.

Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea.

Kimoff RJ, Hamid Q, Divangahi M, Hussain S, Bao W, Naor N, Payne RJ, Ariyarajah A, Mulrain K, Petrof BJ.

Eur Respir J. 2011 Jul;38(1):89-97. doi: 10.1183/09031936.00048610. Epub 2010 Sep 16.

47.

Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?

Behar SM, Divangahi M, Remold HG.

Nat Rev Microbiol. 2010 Sep;8(9):668-74. doi: 10.1038/nrmicro2387. Epub 2010 Aug 2. Review.

48.

What's in a name? The (mis)labelling of Crohn's as an autoimmune disease.

Behr MA, Divangahi M, Lalande JD.

Lancet. 2010 Jul 17;376(9736):202-3. doi: 10.1016/S0140-6736(10)60282-6. No abstract available.

PMID:
20638565
49.

Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis.

Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM.

Nat Immunol. 2010 Aug;11(8):751-8. doi: 10.1038/ni.1904. Epub 2010 Jul 11.

50.

Inspiratory resistive breathing induces acute lung injury.

Toumpanakis D, Kastis GA, Zacharatos P, Sigala I, Michailidou T, Kouvela M, Glynos C, Divangahi M, Roussos C, Theocharis SE, Vassilakopoulos T.

Am J Respir Crit Care Med. 2010 Nov 1;182(9):1129-36. doi: 10.1164/rccm.201001-0116OC. Epub 2010 Jul 9.

PMID:
20622034

Supplemental Content

Loading ...
Support Center